NM_000314.8(PTEN):c.759del (p.Lys254_Val255insTer) AND Cowden syndrome 1

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Sep 29, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003452586.1

Allele description [Variation Report for NM_000314.8(PTEN):c.759del (p.Lys254_Val255insTer)]

NM_000314.8(PTEN):c.759del (p.Lys254_Val255insTer)

Gene:

PTEN:phosphatase and tensin homolog [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

10q23.31

Genomic location:

Preferred name:

NM_000314.8(PTEN):c.759del (p.Lys254_Val255insTer)

HGVS:

NC_000010.11:g.87957977del
NG_007466.2:g.99539del
NM_000314.8:c.759delMANE SELECT
NM_001304717.5:c.1278del
NM_001304718.2:c.168del
NP_000305.3:p.Lys254_Val255insTer
NP_000305.3:p.Val255Terfs
NP_001291646.4:p.Lys427_Val428insTer
NP_001291647.1:p.Lys57_Val58insTer
LRG_311t1:c.759del
LRG_311:g.99539del
LRG_311p1:p.Val255Terfs
NC_000010.10:g.89717734del
NM_000314.4:c.759delC

Molecular consequence:

NM_000314.8:c.759del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001304717.5:c.1278del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001304718.2:c.168del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:: Cowden syndrome 1 (CWS1)
Identifiers:: MONDO: MONDO:0008021; MedGen: CN072330; OMIM: 158350

Recent activity

Clear Turn Off Turn On

LOC100782548 [Glycine max]
LOC100782548 [Glycine max]
Gene ID:100782548

Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004189762	Myriad Genetics, Inc.	criteria provided, single submitter (Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))	Pathogenic (Sep 29, 2023)	unknown	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004189762

Myriad Genetics, Inc.

criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))

Pathogenic
(Sep 29, 2023)

unknown

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Myriad Genetics, Inc., SCV004189762.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Dec 30, 2023

ClinVar

Relating variation to medicine